EFFECT OF INTRADUODENAL ADMINISTRATION OF 23-METHYL-UDCA DIASTEREOISOMERS ON BILE-FLOW IN HAMSTERS

被引:4
作者
CLERICI, C
DOZZINI, G
DISTRUTTI, E
GENTILI, G
SADEGHPOUR, BM
NATALINI, B
PELLICCIARI, R
RIZZOLI, R
RODA, A
PELLI, MA
MORELLI, A
机构
[1] UNIV PERUGIA,IST CHIM FARMACEUT & TECN FARMACEUT,I-06100 PERUGIA,ITALY
[2] UNIV MESSINA,IST CHIM ANALIT,I-98100 MESSINA,ITALY
关键词
23-METHYL-URSODEOXYCHOLIC ACID; BILE FLOW; LIVER BIOTRANSFORMATION; CRITICAL MICELLAR CONCENTRATION;
D O I
10.1007/BF01296441
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
3-alpha,7-beta-Dihydroxy-23-methyl-5-beta-cholan-24-oic acid (MUDCA) and its two diastereoisomers, alpha- and beta-MUDCA, were infused intraduodenally in biliary fistula hamsters in order to evaluate the effect on bile flow and their hepatic biotransformation processes compared with the natural analog ursodeoxycholic acid (UDCA). In addition, the corresponding glycine conjugates were compared. The bile acids were administered at different doses (0.7-6-mu-mol/min/kg) over periods of 90 min. The results indicate that the racemic mixture exhibits a potent choleretic effect at both low and high doses, while the two individual diastereoisomers show this effect only at high doses. The presence of a C-23 methyl group in the side chain prevents hepatic amidation and alternative conjugations occur, such as glucuronidation, in order to facilitate their biliary secretion. Biotransformation of the methyl derivatives of UDCA occurred mainly by conversion to more polar glucuronide conjugates. There was little alteration to the molecule and, unlike UDCA, very little amidation occurred. These data indicate that the presence of a C-23 methyl group prevents the usual side-chain amidation common to the most naturally occurring bile acids and that glucuronidation is a requisite for efficient biliary excretion.
引用
收藏
页码:791 / 798
页数:8
相关论文
共 21 条
  • [1] BATESON MC, 1989, LANCET, V1, P898
  • [2] EFFECT OF URSODEOXYCHOLIC ACID TREATMENT ON ALANINE AMINOTRANSFERASE AND GAMMA-GLUTAMYL-TRANSPEPTIDASE SERUM LEVELS IN PATIENTS WITH HYPERTRANSAMINASEMIA - RESULTS FROM A DOUBLE-BLIND CONTROLLED TRIAL
    BELLENTANI, S
    TABARRONI, G
    BARCHI, T
    FERRETTI, I
    FRATTI, N
    VILLA, E
    MANENTI, F
    [J]. JOURNAL OF HEPATOLOGY, 1989, 8 (01) : 7 - 12
  • [3] CASTAGNOLA V, 1984, Patent No. 135782
  • [4] BILE-ACID GLYCINE AND TAURINE CONJUGATES IN SERUM OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS - EFFECT OF URSODEOXYCHOLIC TREATMENT
    CHRETIEN, Y
    POUPON, R
    GHERARDT, MF
    CHAZOUILLERES, O
    LABBE, D
    MYARA, A
    TRIVIN, F
    [J]. GUT, 1989, 30 (08) : 1110 - 1115
  • [5] GURANTZ D, 1984, AM J PHYSIOL, V247, pG738
  • [6] HOFMANN AF, 1962, J LIPID RES, V3, P127
  • [7] HOFMANN AF, 1984, J LIPID RES, V25, P1477
  • [8] Krebs K. G., 1969, THIN LAYER CHROMATOG, P854
  • [9] URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS - RESULTS OF A CONTROLLED DOUBLE-BLIND TRIAL
    LEUSCHNER, U
    FISCHER, H
    KURTZ, W
    GULDUTUNA, S
    HUBNER, K
    HELLSTERN, A
    GATZEN, M
    LEUSCHNER, M
    [J]. GASTROENTEROLOGY, 1989, 97 (05) : 1268 - 1274
  • [10] CLASS SEPARATION OF BILE LIPIDS BY THIN-LAYER CHROMATOGRAPHY
    NAKAGAKI, M
    NAKAYAMA, F
    [J]. JOURNAL OF CHROMATOGRAPHY, 1979, 177 (02): : 343 - 348